Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.6963
H.R.6963: Accelerated Approval Integrity Act of 2022
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced March 7, 2022
- Latest Major Action March 8, 2022
Bill Sponsor
Bill Cosponsor
Bill Version
- Introduced in House - March 7, 2022
Bill Summary
Accelerated Approval Integrity Act of 2022 This bill establishes requirements relating to postapproval studies for drugs that receive accelerated approval for serious or life-threatening diseases or conditions, such as requiring product sponsors to agree in advance to conduct such studies and terminating product approval if certain benchmarks are not met.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
| March 8, 2022 |
Referred to the Subcommittee on Health.
|
| March 7, 2022 |
Referred to the House Committee on Energy and Commerce.
|
| March 7, 2022 |
Introduced in the House by Frank Pallone (D-N.J.) |